Globus Medical, Inc. (GMED)

NYSE Currently down 2.95 (-3.25%) in today's trading session

2 members of Congress have disclosed 4 trades in Globus Medical, Inc. (GMED) via STOCK Act filings. The most recent disclosure was a sale by Lisa McClain on 10 July 2025. The most active traders have been Lisa McClain (3) and Josh Gottheimer (1). Aggregate disclosed activity totals roughly $16K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Globus Medical, Inc. is currently trading at $87.79, positioned at 73% of its 52-week range ($51.79 – $101.40).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$87.79
24h Change
-2.95 (-3.25%)
52 Week Range
$51.79$101.40
View on NASDAQ

Globus Medical, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for GMED

Select to highlight on chart
2 transactions
Compliance: 50%
Lisa McClain10 Jul 202513 Aug 2025SaleStock$1,001 - $15,000N/A
Josh Gottheimer3 Apr 202319 May 2023PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$11.87B

Volume

894.15K

Beta

1.09

P/E Ratio

22.40

Fundamentals

EPS

$3.92

Div. Yield

Open

$90.22

Day Range

$87.51 — $90.69

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE · USD
Country
US
CEO
Keith W. Pfeil
IPO Date
2012-08-03

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants compr...

Earnings

Next Report

Q1 2026

7 May

EPS Est.

$0.92

Rev. Est.

$740.3M

Days Until

7

Recent Quarters

Q4 202524 Feb
EPS$1.28
Beat 20.8%
Q3 20256 Nov
EPS$1.18
Beat 51.1%
Q2 20257 Aug
EPS$0.86
Beat 13.2%
Q1 20258 May
EPS$0.68
Miss 8.6%
Q4 202420 Feb
EPS$0.84
Beat 13.5%
Q3 20245 Nov
EPS$0.83
Beat 28.3%
Q2 20246 Aug
EPS$0.75
Beat 10.3%
Q1 20247 May
EPS$0.72
Beat 27.0%
Q4 202320 Feb
EPS$0.60
Beat 1.7%
Q3 20237 Nov
EPS$0.57
Beat 5.6%
Q2 20233 Aug
EPS$0.63
Beat 6.8%
Q1 20234 May
EPS$0.53
Beat 3.9%
Q4 202221 Feb
EPS$0.59
Beat 5.4%
Q3 20228 Nov
EPS$0.50
Miss 3.9%
Q2 20224 Aug
EPS$0.56
Beat 5.7%
Q1 202210 May
EPS$0.42
Miss 10.6%
Q4 202117 Feb
EPS$0.49
Beat 2.1%
Q3 20214 Nov
EPS$0.50
Beat 11.1%
Q2 20214 Aug
EPS$0.56
Beat 24.4%
Q1 20214 May
EPS$0.49
Beat 32.4%
Q4 202017 Feb
EPS$0.58
Beat 13.7%
Q3 202028 Oct
EPS$0.49
Beat 63.3%
Q2 20205 Aug
EPS$0.07
Beat 163.6%
Q1 20207 May
EPS$0.29
Miss 23.7%
Q4 201920 Feb
EPS$0.49
Miss 5.8%
Q3 20196 Nov
EPS$0.43
Beat 2.4%
Q2 20191 Aug
EPS$0.41
Beat 0.0%
Q1 20192 May
EPS$0.36
Miss 12.2%
Q4 201821 Feb
EPS$0.43
Beat 10.3%
Q3 20188 Nov
EPS$0.39
Beat 21.9%
Q2 20181 Aug
EPS$0.44
Beat 25.7%
Q1 20182 May
EPS$0.41
Beat 13.9%
Q4 201721 Feb
EPS$0.38
Beat 8.6%
Q3 20178 Nov
EPS$0.30
Beat 0.0%
Q2 20172 Aug
EPS$0.32
Beat 6.7%
Q1 20173 May
EPS$0.32
Beat 3.2%
Q4 201627 Feb
EPS$0.31
Miss 6.1%
Q3 20168 Nov
EPS$0.29
Beat 0.0%
Q2 201626 Jul
EPS$0.29
Beat 0.0%
Q1 20163 May
EPS$0.29
Beat 3.6%
Q4 201524 Feb
EPS$0.32
Beat 6.7%
Q3 20153 Nov
EPS$0.28
Beat 12.0%
Q2 201530 Jul
EPS$0.25
Beat 0.0%
Q1 20155 May
EPS$0.26
Beat 8.3%
Q4 201425 Feb
EPS$0.30
Beat 20.0%
Q3 201430 Oct
EPS$0.24
Beat 14.3%
Q2 20145 Aug
EPS$0.23
Beat 0.0%
Q1 201429 Apr
EPS$0.24
Beat 9.1%
Q4 201326 Feb
EPS$0.25
Beat 13.6%
Q3 201330 Oct
EPS$0.22
Beat 15.8%
Q2 20131 Aug
EPS$0.21
Beat 5.0%
Q1 20132 May
EPS$0.21
Beat 5.0%
Q4 201227 Feb
EPS$0.22
Beat 15.8%
Q3 20122 Nov
EPS$0.18
Q3 20121 Nov
EPS$0.18
Miss 5.3%
Q4 201131 Mar
EPS$0.23
Q3 201131 Dec
EPS$0.15
Q2 201130 Sept
EPS$0.19
Q1 201130 Jun
EPS$0.21
Q4 201031 Mar
EPS$0.19

1 politician traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

NVDA

NVIDIA Corporation

20
$209.25-3.82 (-1.79%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

PTSNX

PIMCO Short Term I-3

17
$9.680.00 (0.00%)
Held by same politician
1 politician
View Stock

GOOG

Alphabet Inc.

17
$347.31-0.19 (-0.05%)
Communication Services
Held by same politician
1 politician
View Stock

Frequently Asked Questions about GMED

Which members of Congress have traded GMED?
2 members of Congress have disclosed 4 trades in Globus Medical, Inc. (GMED) under the STOCK Act. The most active traders are Lisa McClain and Josh Gottheimer.
When was GMED most recently disclosed by Congress?
The most recent GMED disclosure was a sale by Lisa McClain on 10 July 2025.
What is the total disclosed congressional trading volume for GMED?
Members of Congress have disclosed approximately $16K in GMED purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in GMED?
This GMED page updates as soon as new STOCK Act disclosures are filed for Globus Medical, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi TrackerJoin our Discord
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.